Reporting of adverse events ONLY

Patients should always seek the advice of a doctor or pharmacist in case of adverse events.

If you wish to report an adverse event to ELC Group s.r.o., please find the contact information below:

00420 224 910 672

(from 09.00-17.30 CET)

00420 723 694 460

(non-stop 24/7)

To contact us about any other issue please call:

+420 22 491 0000or our regional offices.

Hlášení nežádoucích príhod

Pacienti by meli vždy požádat o radu svého lékare nebo lékárníka v prípade výskytu nežádoucích príhod.

Pokud chcete nahlásit nežádoucí príhodu spolecnosti ELC Group s r.o., prosím využijte kontaktních údaju níže:

00420 224 910 672

(09.00-17.30 CET)

00420 723 694 460

(non-stop 24/7)

Pro záležitosti, které se netýkaji farmakovigilance, kontaktujte prosím recepci:

+420 22 491 0000 nebo naše další pobočky.

Medical Devices

Our Medical Device division can help you with your projects in new regions, with finding new distributors, registering your products on many markets and having a local representative when needed, etc.

European Economic Area

Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, United Kingdom

  • CE Marking
  • Distributor search
  • Clinical Evaluation Report
  • Pricing and reimbursement

Commonwealth of Independent States (CIS)

Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Armenia, Moldova, Russia, Tajikistan, Uzbekistan, Ukraine & Georgia

  • Advise on classification and family grouping
  • Registration & Life-Cycle Management
  • Toxicity studies, Technical & Clinical trials, laboratory comparative analysis, EMI & EMC testing
  • Communication with the local authorities
  • Coordination of testing, application and registration fees
  • Declaration of Conformity (DoC)
  • Local Representation
  • Ad hoc advice and Consulting
  • Pricing and Reimbursement
  • Market Analysis

Oceania

Australia, New Zealand

  • Advise on classification and family grouping
  • Registration & Life-Cycle Management
  • Toxicity studies, Technical & Clinical trials, laboratory comparative analysis, EMI & EMC testing
  • Communication with the local authorities
  • Coordination of testing, application and registration fees
  • Declaration of Conformity (DoC)
  • Local Representation
  • Ad hoc advice and Consulting
  • Pricing and Reimbursement
  • Market Analysis

Asia

China, Malaysia, Singapore, Vietnam

  • Advise on classification and family grouping
  • Registration & Life-Cycle Management
  • Toxicity studies, Technical & Clinical trials, laboratory comparative analysis, EMI & EMC testing
  • Communication with the local authorities
  • Coordination of testing, application and registration fees
  • Declaration of Conformity (DoC)
  • Local Representation
  • Ad hoc advice and Consulting
  • Pricing and Reimbursement
  • Market Analysis

Latin America

Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, Guatemala, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela

  • Advise on classification and family grouping
  • Registration & Life-Cycle Management
  • Toxicity studies, Technical & Clinical trials, laboratory comparative analysis, EMI & EMC testing
  • Communication with the local authorities
  • Coordination of testing, application and registration fees
  • Declaration of Conformity (DoC)
  • Local Representation
  • Ad hoc advice and Consulting
  • Pricing and Reimbursement
  • Market Analysis